- World Health Organization. Coronavirus disease (COVID-19) dashboard. https://covid19.who.int/. Accessed January 2022.
- Puliatti S, Eissa A, Eissa R, et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int. 2020;125(6):E7–E14. doi:10.1111/bju.15071.
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
- Achua JK, Chu KY, Ibrahim E, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections on testis. World J Mens Health. 2021;39(1):65–74. doi:10.5534/wjmh.200170.
- Kresch E, Achua J, Saltzman R, et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. World J Mens Health. 2021;39(3):466–469. doi:10.5534/wjmh.210055.
- Chu KY, Nackeeran S, Horodyski L, Masterson TA, Ramasamy R. COVID-19 infection is associated with new onset erectile dysfunction: insights from a national registry. Sex Med. 2022;10(1):100478. doi:10.1016/j.esxm.2021.100478.
- Creta M, Sagnelli C, Celentano G, et al. SARS-CoV-2 infection affects the lower urinary tract and male genital system: a systematic review. J Med Virol. 2021;93(5):3133–3142. doi:10.1002/jmv.26883.
- Kaya Y, Kaya C, Kartal T, Tahta T, Tokgöz VY. Could LUTS be early symptoms of COVID-19. Int J Clin Pract. 2021;75(3):e13850. doi:10.1111/ijcp.13850.
- Can O, Erkoç M, Ozer M, Karakanli MU, Otunctemur A. The effect of COVID-19 on lower urinary tract symptoms in elderly men. Int J Clin Pract. 2021;75(6):e14110. doi:10.1111/ijcp.14110.
- Cinislioglu AE, Demirdogen SO, Cinislioglu N, et al. Variation of serum PSA levels in COVID-19 infected male patients with benign prostatic hyperplasia (BPH): a prospective cohort study. Urology. 2022;159:16–21. doi:10.1016/j.urology.2021.09.016.
- Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185–192. doi:10.1007/s11684-020-0754-0.
- Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int. 2020;97(5):824–828. doi:10.1016/j.kint.2020.03.001.
- Dhar N, Dhar S, Timar R, Lucas S, Lamb LE, Chancellor MB. De novo urinary symptoms associated with COVID-19: COVID-19–associated cystitis. J Clin Med Res. 2020;12(10):681–682. doi:10.14740/jocmr4294.
- Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–1844. doi:10.1001/jama.2020.3786.
- Haghpanah A, Masjedi F, Salehipour M, Hosseinpour A, Roozbeh J, Dehghani A. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms? A systematic review. Prostate Cancer Prostatic Dis. 2022;25(1):27–38. doi:10.1038/s41391-021-00388-3.
- Marand AJB, Bach C, Janssen D, et al. Lower urinary tract signs and symptoms in patients with COVID-19. BMC Infect Dis. 2021;21(1):706. doi:10.1186/s12879-021-06394-z.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
Original Research
Molecular detection of the COVID-19 genome in prostatic tissue of patients with previous infection
Mohamed Elsaqaa Alexandria University, Alexandria, Egypt;b Division of Urology, Department of Surgery, Baylor Scott & White Medical Center – Temple, Temple, TexasCorrespondence[email protected]
https://orcid.org/0000-0003-3341-3648
, MDhttps://orcid.org/0000-0003-3341-3648, , MD, PhD, , MD, , MD, , BS, , MD, , BS & , MD, PhD show all